A novel KRT14 null mutation leads to autosomal recessive epidermolysis bullosa simplex
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llac129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Lauren Banner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Cutaneous Biology, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Simplex. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: NCI.
Abstract (Originalsprache)
We describe a novel homozygous KRT14 (also known as K14) mutation detected in a patient with a relatively mild form of epidermolysis bullosa simplex (EBS). Our patient harbours loss of function of both alleles of the KRT14 gene. This is the 16th reported mutation of recessive EBS in KRT14.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Cutaneous Biology, Philadelphia, PA, USA.
- The Joan and Joel Rosenbloom Research Center for Fibrotic Diseases, Philadelphia, PA, USA.
- Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Förderung
- NCI
Zitieren
APA
Banner, L., Cohen, A., McGrath, L., Nikbakht, N., & South, A. P. (2023). A novel KRT14 null mutation leads to autosomal recessive epidermolysis bullosa simplex. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llac129
Vancouver
Banner L, Cohen A, McGrath L, Nikbakht N, South AP. A novel KRT14 null mutation leads to autosomal recessive epidermolysis bullosa simplex. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llac129
BibTeX
@article{Banner2023,
author = {Banner, Lauren and Cohen, Alexa and McGrath, Lauren and Nikbakht, Neda and South, Andrew P},
title = {A novel KRT14 null mutation leads to autosomal recessive epidermolysis bullosa simplex},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llac129}
}
EUVIMED